Status:
UNKNOWN
Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
The Swedish Research Council
Conditions:
Neurodevelopmental Disorders
Autism
Eligibility:
All Genders
2-18 years
Brief Summary
The overall project aim is to study children's neurodevelopmental outcomes (including diagnoses of autism, ADHD, and intellectual disability) following exposure to maternal anemia during pregnancy or ...
Detailed Description
Our overall hypothesis is that early life iron sufficiency may promote appropriate neurodevelopment and reduce risk of neurodevelopmental disorders in children. We will use Swedish register data to de...
Eligibility Criteria
Inclusion
- children born in Sweden from January 1, 1987 to December 31, 2010 (national cohort)
- children born in Region Stockholm from January 1, 2007 to December 31, 2010 (Stockholm regional cohort)
Exclusion
- Adopted children
- Children without records in the Medical Birth Registry (MBR)
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
2400000 Patients enrolled
Trial Details
Trial ID
NCT06199362
Start Date
August 15 2023
End Date
December 1 2024
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Sweden, 17177